HIGHLIGHTS
- who: Bruna Lo Sasso from the DepartmentUniversity of Palermo, Palermo, Italy have published the research work: Longitudinal analysis of anti-SARS-CoV-2 S-RBD IgG antibodies before and after the third dose of the BNT162b2 vaccine, in the Journal: Scientific Reports Scientific Reports of 25/Nov/2020
SUMMARY
A total of 1013 (M:453, F:560) naïve infection individuals underwent multiple anti-S-RBD IgG level measurements post-vaccination. The median (IQR) anti-S-RBD IgG levels at the first measurement (baseline) were 1206 BAU/mL. Females displayed significantly higher median . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.